Method for performing stereotactic laser surgery

• US 5,785,704 A
• Filed: 07/29/1996
• Issued: 07/28/1998
• Est. Priority Date: 07/29/1996
• Status: Expired due to Fees

• Current Assignee: MRC Systems GmbH
• Original Assignee: MRC Systems GmbH
• Inventors: Goetz, Marcus H., Bille, Joseph F., Sturm, Volker
• Primary Examiner(s): Peffley, Michael
• Application Number:
  US08/688,039
• Time in Patent Office: 729 Days
• Field of Search: 606/7, 606/10-19, 606/130, 128/898, 607/88, 607/89, 600/108
• US Class Current: 606/17
• CPC Class Codes: A61B 18/24 with a catheter A61B18/26, A61B18/28 take precedence
• CPC Class Codes: A61B 8/0808 for diagnosis of the brain
• CPC Class Codes: A61B 90/10 for stereotaxic surgery, e.g. frame-based stereotaxis

Abstract

A method for the photodisruption of tissue using a laser beam for stereotactic laser neurosurgery includes the initial step of positioning the distal end of a probe into the tissue to be photodisrupted. A laser beam having laser pulses of picosecond or femtosecond duration is then directed along a beam path through the probe. Using a focusing lens, which is slidably positioned on the beam path in the probe, and a light reflector, which is slidably positioned on the beam path at the distal end of the probe, the laser beam is focused to a focal point that is located on a line substantially perpendicular to the beam path through the probe. By concerted movement of the lens and mirror, predetermined cylindrical layers of tissue can be photodisrupted. Specifically, a rotation of the mirror causes photodisruption of tissue along a circular arc and a simultaneous movement of the lens and mirror allows for photodisruption of additional arcs on a cylindrical surface. Further, by moving the lens relative to the mirror, cylindrical tissue surfaces having different radii can be photodisrupted. Additionally, the area of tissue photodisruption can be irrigated and aspirated during practice of the method.

Claims

1. A method for using a laser beam in stereotactic laser neurosurgery for the photodisruption of malignant tissue which comprises the steps of:

locating a hollow probe to establish extracorporeal access to the tissue to be photodisrupted, said hollow probe having a proximal end and a distal end and being formed with a channel;

selectively placing a light reflector near said distal end of said probe;

directing said laser beam on a beam path through said channel of said probe for reflection from said light reflector in a direction away from said beam path;

positioning a lens in said channel proximal to said light reflector to focus said laser beam at a desired focal point;

moving said light reflector, in concert with movement of said lens, to move said focal point in a predetermined manner for photodisruption of the tissue;

rinsing said light reflector with a solution; and

aspirating said solution together with photodisrupted debris from around said tissue.

2. A method as recited in claim 1 wherein said moving step further comprises the steps of:

rotating said light reflector through an arc to photodisrupt tissue at a predetermined radial distance from said light reflector along said arc; and

simultaneously moving said light reflector and said lens in a proximal/distal direction through an equal distance to photodisrupt tissue along successive arcs in said proximal/distal direction.

3. A method as recited in claim 2 wherein said arc is approximately three hundred and sixty degrees.

4. A method as recited in claim 3 wherein a range for movement in said proximal/distal direction is approximately twenty millimeters.

5. A method as recited in claim 4 further comprising the step of moving said lens in said proximal/distal direction relative to said light reflector to vary said radial distance of said focal point relative to said light reflector.

6. A method as recited in claim 5 wherein photodisruption of said tissue creates a plasma spade and said method further comprises the step of controlling the movement of said lens in said proximal distal direction relative to said light reflector, by detecting the light of the plasma spark to measure the position of said focal point relative to the current tissue surface.

7. A method as recited in claim 6 wherein said laser beam has a waveform and said method further comprises the step of controlling the waveform of the laser beam by an active mirror.

8. A method as recited in claim 7 further comprising a step of controlling the waveform of the laser beam by a spatial light modulator.

9. A method as recited in claim 6 further comprising the steps of:

measuring an intracranial pressure; and

controlling the intracranial pressure on said tissue at a preselected level.

10. A method as recited in claim 1 wherein said laser beam has an energy density of approximately 50 J/cm².

11. A method as recited in claim 1 wherein said laser beam comprises a plurality of pulses having a pulse duration in the range of from one hundredth to one hundred picoseconds.

12. A method as recited in claim 11 wherein each said pulse in said laser beam has a pulse energy of approximately 2.5 mJ and a repetition rate for said pulses of said laser beam is approximately 4 kHz.

13. A method as recited in claim 1 further comprising the steps of:

delaying said moving step to fix said focal point at a position for a predetermined period of time; and

defocusing said laser beam to coagulate blood at said position.

14. A method as recited in claim 13 further comprising the steps of:

identifying a blood vessel in the tissue to be photodisrupted; and

performing said delaying step and said defocusing step on said blood vessel.

15. A method as recited in claim 14 wherein said identifying step is accomplished using a confocal laser scanning microscope for real time viewing of the tissue.

16. A method as recited in claim 14 wherein said identifying step is accomplished using a laser doppler flowmeter for real time viewing of the tissue.

17. A method as recited in claim 14 wherein said identifying step includes the steps of:

dying the tissue to be photodisrupted;

exciting the dyed tissue with a laser pulse having a fixed wavelength to create a fluorescent intensity; and

measuring the fluorescent intensity of the tissue as an indication and identification of the tissue to be photodisrupted.

18. A method as recited in claim 17 wherein said dying step is accomplished using Hematoporphyrin Derivate (HpD).

19. A method as recited in claim 14 wherein said identifying step includes the steps of:

dying the tissue to be photodisrupted;

exciting the dyed tissue with a laser pulse having a fixed wavelength to generate a fluorescence in the tissue after a time delay; and

measuring the time delay of fluorescence as an indication and identification of the tissue to be photodisrupted.

20. A method as recited in claim 19 wherein said dying step is accomplished using Hematoporphyrin Derivate (HpD).

21. A method as recited in claim 1 further comprising the steps of determining a boundary between the malignant tissue to be photodisrupted and healthy tissue.

22. A method as recited in claim 21 wherein said determining step is accomplished using ultrasound imaging for real time viewing of the tissue.

23. A method as recited in claim 21 wherein said determining step is accomplished using a confocal laser scanning microscope for real time viewing of the tissue.

24. A method as recited in claim 21 wherein said determining step is accomplished using a laser doppler flowmeter for real time viewing of the tissue.

25. A method as recited in claim 21 wherein said determining step includes the steps of:

dying the tissue to be photodisrupted;

exciting the dyed tissue with a laser pulse having a fixed wavelength to create a fluorescent intensity; and

measuring the fluorescent intensity of the tissue as an indication and identification of the tissue to be photodisrupted.

26. A method as recited in claim 1 further comprising the steps of:

constructing a magnetic resonance image of the tissue to be photodisrupted;

viewing the tissue to be photodisrupted using a confocal laser scanning microscope to generate a real time image of the tissue to be photodisrupted;

and

comparing said magnetic resonance image with said real time image to accomplish said directing step.

27. A method as recited in claim 1 further comprising the steps of:

constructing a magnetic resonance image of the tissue to be photodisrupted;

viewing the tissue to be photodisrupted using a laser doppler flowmeter to generate a real time image of the tissue to be photodisrupted; and

comparing said magnetic resonance image with said real time image to accomplish said directing step.

28. A method as recited in claim 1 wherein said predetermined manner in said step of moving said mirror creates a separate piece of the tissue to be photodisrupted.

29. A method as recited in claim 1 further comprising the steps of:

constructing a magnetic resonance image of the tissue to be photodisrupted;

generating a first signal, said first signal being a characteristic of said magnetic resonance image;

viewing the tissue to be photodisrupted using a laser doppler flowmeter to generate a real time image of the tissue to be photodisrupted;

generating a second signal, said second signal being characteristic of said real time image;

comparing said first signal of said magnetic resonance image with said second signal of said real time image to create an error signal; and

accomplishing said moving step to minimize said error signal.

30. A method as recited in claim 1 further comprising the steps of:

locating a balloon catheter near said distal end of said probe; and

shifting outwards the tissue by inflating said balloon catheter.

31. A method as recited in claim 1 wherein said solution is isotonic natrium chloride.

32. A device for using a laser beam in stereotactic laser neurosurgery for the photodisruption of malignant tissue which comprises:

a hollow probe assembly formed with a channel and having a proximal end and a distal end;

a source of laser light connected in light communication with said proximal end of said probe to direct a beam of laser light through said channel from said proximal end toward said distal end;

a reflector slidably and rotatably mounted on said distal end of said probe for selectively directing said laser beam from said probe toward the malignant tissue;

a lens system for focusing said laser beam at a focal point on said malignant tissue distal from said reflector to generate photodisrupted debris;

irrigation means for rinsing said reflector with a solution; and

aspiration means for aspirating said solution with said photodisrupted debris from said tissue.

33. A device as recited in claim 32 wherein said reflector is a mirror.

34. A device as recited in claim 32 wherein said reflector is a prism.

35. A device as recited in claim 32 wherein said lens system further comprises an active mirror for focusing said laser beam.

36. A device as recited in claim 32 wherein said lens system further comprises a liquid crystal light valve for focusing said laser beam.

37. A device as recited in claim 32 further comprising means for real time imaging of said malignant tissue, said real time imaging means being mounted in light communication with said channel of said probe via said proximal end thereof.

38. A device as recited in claim 37 wherein said means for real time imaging further comprises an ultrasonic probe.